Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-19-000039
Filing Date
2019-06-05
Accepted
2019-06-05 16:32:23
Documents
1
Period of Report
2019-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5474
  Complete submission text file 0001179022-19-000039.txt   7004
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALECTIN THERAPEUTICS, INC. 7 WELLS AVENUE, SUITE 34 NEWTON MA 02459
Business Address
Shlevin Harold H. (Reporting) CIK: 0001557082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 19880067